Researchers at Weill Cornell Medicine have identified a key protein that induces the program to build specialized liver blood vessels. The discovery could lead to engineered replacement hepatic tissue to treat common liver diseases.
Five Weill Cornell Medicine instructors and junior faculty seeking to pursue independent research careers have received 2021 JumpStart Career Development awards.